|
|
|
Insider
Information: |
Rosenberg Noah L. |
Relationship: |
Chief Medical Officer |
City: |
Plymouth |
State: |
MI |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
47,614 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$367,580 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
47,614 |
|
|
Total
Value |
$367,580 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
169.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Travere Therapeutics, Inc |
TVTX |
Chief Medical Officer |
2021-08-17 |
47,614 |
2018-07-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
22,500 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
29,045 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
29,055 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
42,720 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
47,720 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
48,594 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
49,021 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-05-11 |
4 |
AS |
$19.14 |
$7,178 |
D/D |
(375) |
45,969 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-05-12 |
4 |
AS |
$19.46 |
$7,298 |
D/D |
(375) |
45,594 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-05-12 |
4 |
S |
$16.98 |
$8,951 |
D/D |
(527) |
26,728 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-09-23 |
4 |
AS |
$18.48 |
$13,860 |
D/D |
(750) |
27,555 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-09-22 |
4 |
AS |
$18.59 |
$13,943 |
D/D |
(750) |
28,305 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-07-28 |
4 |
AS |
$13.81 |
$17,263 |
D/D |
(1,250) |
44,521 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-07-28 |
4 |
S |
$20.49 |
$17,826 |
D/D |
(870) |
26,055 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-08-17 |
4 |
S |
$17.12 |
$24,085 |
D/D |
(1,407) |
47,614 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2019-07-30 |
4 |
AS |
$19.82 |
$24,775 |
D/D |
(1,250) |
14,750 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2019-07-31 |
4 |
AS |
$20.07 |
$25,088 |
D/D |
(1,250) |
13,500 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2020-03-05 |
4 |
S |
$15.36 |
$27,487 |
D/D |
(1,790) |
27,255 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-02-05 |
4 |
AS |
$31.41 |
$35,336 |
D/D |
(1,125) |
47,469 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-02-08 |
4 |
AS |
$31.58 |
$35,528 |
D/D |
(1,125) |
46,344 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-02-03 |
4 |
AS |
$28.91 |
$52,414 |
D/D |
(1,813) |
44,094 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Medical Officer |
|
2021-02-02 |
4 |
AS |
$30.75 |
$55,750 |
D/D |
(1,813) |
45,907 |
0 |
% |
|
24 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|